Medical licensing board objects to Utah AI prescription refill experiment
Utah's experiment with AI-generated prescription refills has raised concerns among medical professionals, with the Utah Medical Licensing Board calling for the program's suspension due to potential risks to patients. The board argues that licensed practitioners should oversee prescription refills for safety and clinical reasons.
Utah's Office of Artificial Intelligence Policy and the startup Doctronic have partnered to allow AI to renew prescriptions for nearly 200 medications. The Utah Medical Licensing Board has objected, citing concerns that the program potentially places Utah citizens at risk. The board insists that licensed practitioners should oversee prescription refills. The AI system asks patients questions and renews prescriptions for medications such as blood pressure medication and asthma inhalers. Doctronic has excluded higher-risk drugs and has 20 doctors available for consultation if issues arise. The program's future is uncertain as the medical community debates its safety and efficacy.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.